Sept 23 (Reuters) – Pharma Mar SA: * RECEIVES FDA CLEARANCE FOR PM54 PLATFORM TRIAL STARFISH-54 TO ACCELERATE COMBINATION DEVELOPMENT ACROSS SOLID TUMORS Source text Further company coverage: (Gdansk
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
MUMBAI, Sept 23 (Reuters) - STOCKS: The benchmark BSE Sensex was up 0.5% at 74,940,…
SINGAPORE, Sept 23 (Reuters) - Top executives of Grab bought more than $30 million worth…
Sept 23 (Reuters) - Poland's registered unemployment rate remained flat at 5.8% in August compared…
SINGAPORE, Sept 23 (Reuters) - Top executives of Grab bought more than $30 million worth…
(Adds details, background) ZURICH, Sept 23 (Reuters) - Switzerland's upper house of parliament on Wednesday…
(For a Reuters live blog on U.S., UK and European stock markets, click or type…